Retatrutide (LY3437943) - triple GLP-1/GIP/glucagon receptor co-agonist for advanced multi-incretin metabolic signaling research.
Retatrutide (LY3437943) is a first-in-class triple co-agonist simultaneously activating three incretin/glucagon receptors: GLP-1R, GIPR, and GcgR. This tri-agonist approach enables simultaneous study of all three major metabolic regulatory axes. The fatty acid-conjugated 39-mer peptide has a prolonged half-life suitable for once-weekly dosing in animal research models.
SPPS synthesis with fatty acid conjugation; HPLC >=99%; LC-MS confirmed; endotoxin tested. Full CoA provided.
For Research Use Only. Not for human or veterinary use.
| Product Name | Reta |
| CAS Number | 2381272-90-6 |
| Purity | ≥99% (by HPLC) |
| Molecular Weight | 5,209.82 g/mol |
| Molecular Formula | C234H365N53O71 |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C. |
| Available Sizes | 10mg · Custom |
Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.
Reta · CAS 2381272-90-6
Quote request sent! We'll respond within 24 hours.
